Agilent Technologies, Inc. (A) Earnings Call Analysis

NYSE · Healthcare · Diagnostics & Research

Earnings Reports

• Agilent (A) Q2 2026: Ignite Pricing Delivers 200bps Margin Tailwind, Outpacing End-Market Growth
  May 28, 2026
• Agilent (A) Q1 2026: Advanced Materials Surge 20%, Ignite Drives Margin Expansion Trajectory
  February 26, 2026
• Agilent (A) Q4 2025: Ignite Delivers $150M+ Savings, Margin Expansion Anchors FY26 Guide
  November 25, 2025
• Agilent (A) Q3 2025: Tariff Costs Jump $70M as Ignite Drives 6.1% Core Growth Momentum
  August 27, 2025
• Agilent (A) Q2 2025: Ignite Delivers $130M Profit Amid Tariff Headwinds and 70% PFAS Growth
  July 03, 2025
• Agilent (A) Q4 2024: Ignite Restructuring Targets 70bps Margin Expansion Amid 400bp Sequential Recovery
  November 25, 2024
• Agilent (A) Q3 2024: CrossLab Margins Hit 34% as Recurring Revenue Anchors Stability
  August 21, 2024
• Agilent (A) Q2 2024: $300M Guidance Cut as Pharma and China Headwinds Deepen
  May 29, 2024
• Agilent (A) Q1 2024: Services Contracts Drive Double-Digit Growth as Instruments Drop 20%
  February 27, 2024
• Agilent (A) Q4 2023: Free Cash Flow Surges 44% Amid Market Stabilization Signals
  November 20, 2023

Browse all companies